450 related articles for article (PubMed ID: 23098744)
21. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection.
Yang Q; Kang J; Zheng L; Wang XJ; Wan N; Wu J; Qiao Y; Niu P; Wang SQ; Peng Y; Wang Q; Yu W; Chang J
J Med Chem; 2015 May; 58(9):3693-703. PubMed ID: 25905540
[TBL] [Abstract][Full Text] [Related]
23. Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant HBV clinical isolates.
Zhou Y; Zhang Y; Yang X; Zhao J; Zheng L; Sun C; Jiang J; Yang Q; Wang Q; Chang J
Antivir Ther; 2012; 17(8):1593-9. PubMed ID: 22910281
[TBL] [Abstract][Full Text] [Related]
24. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
25. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
27. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
[TBL] [Abstract][Full Text] [Related]
28. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
29. A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.
Zeng Z; Zhang Q; Hong W; Xie Y; Liu Y; Li W; Wu Y; Cao Z
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128943
[TBL] [Abstract][Full Text] [Related]
30. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
32. Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.
Li Y; Liu Z; Hui L; Liu X; Feng A; Wang W; Zhang L; Li N; Zhou G; Wang Q; Han Q; Lv Y; Wang Q; Yang G; Wang Y
Br J Pharmacol; 2017 Jul; 174(14):2261-2272. PubMed ID: 28383135
[TBL] [Abstract][Full Text] [Related]
33. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline].
Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125
[TBL] [Abstract][Full Text] [Related]
34. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
35. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: Rhizomes of Cyperus rotundus.
Xu HB; Ma YB; Huang XY; Geng CA; Wang H; Zhao Y; Yang TH; Chen XL; Yang CY; Zhang XM; Chen JJ
J Ethnopharmacol; 2015 Aug; 171():131-40. PubMed ID: 26051832
[TBL] [Abstract][Full Text] [Related]
36. Anti-Hepatitis B Virus Activity of Esculetin from
Huang SX; Mou JF; Luo Q; Mo QH; Zhou XL; Huang X; Xu Q; Tan XD; Chen X; Liang CQ
Molecules; 2019 Sep; 24(19):. PubMed ID: 31557836
[TBL] [Abstract][Full Text] [Related]
37. [Effect of echinacoside on replication and antigen expression of hepatitis B virus].
Dai LH; Shen YM; Wu YH; Yu XP; Hu HJ; Mi YJ; Chen JJ
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3047-52. PubMed ID: 26677709
[TBL] [Abstract][Full Text] [Related]
38. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
39. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
[TBL] [Abstract][Full Text] [Related]
40. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik.
Wu LL; Yang XB; Huang ZM; Liu HZ; Wu GX
Acta Pharmacol Sin; 2007 Mar; 28(3):404-9. PubMed ID: 17303004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
